• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

    0.1879 -0.0121 (-6.05%)
    Streaming Delayed Price Updated: 3:01 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,807,865
    Open 0.1900
    Bid (Size) 0.1877 (6,800)
    Ask (Size) 0.1880 (15,000)
    Prev. Close 0.2000
    Today's Range 0.1865 - 0.1950
    52wk Range 0.1151 - 2.620
    Shares Outstanding 2,172,309
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
    Via TheNewswire.com

    Performance

    YTD
    -9.2%
    -9.2%
    1 Month
    -54.4%
    -54.4%
    3 Month
    -67.8%
    -67.8%
    6 Month
    -71.3%
    -71.3%
    1 Year
    -92.2%
    -92.2%

    More News

    Read More
    GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week
    Via TheNewswire.com
    News headline image
    GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week
    Via NewMediaWire
    GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA
    Via TheNewswire.com
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Unusual volume stocks are being observed in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Which stocks are moving after the closing bell on Tuesday? ↗
    Via Chartmill
    News headline image
    Unusual volume stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Monday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    News headline image
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    News headline image
    Which stocks are moving on Friday? ↗
    Via Chartmill
    News headline image
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    News headline image
    GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
    Via NewMediaWire
    Topics Regulatory Compliance
    GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
    Via TheNewswire.com
    Topics Regulatory Compliance
    News headline image
    GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine
    Via NewMediaWire
    GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine
    Via TheNewswire.com
    News headline image
    GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA
    Via NewMediaWire
    News headline image
    GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026
    Via NewMediaWire
    Topics Supply Chain
    GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026
    Via TheNewswire.com
    Topics Supply Chain
    News headline image
    GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design
    Via NewMediaWire
    Topics Intellectual Property
    GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design
    Via TheNewswire.com
    Topics Intellectual Property
    News headline image
    GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients
    Via NewMediaWire
    GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients
    Via TheNewswire.com

    Frequently Asked Questions

    Is GeoVax Labs, Inc. - Common Stock publicly traded?
    Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
    What exchange does GeoVax Labs, Inc. - Common Stock trade on?
    GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
    The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
    What is the current price of GeoVax Labs, Inc. - Common Stock?
    The current price of GeoVax Labs, Inc. - Common Stock is 0.1879
    When was GeoVax Labs, Inc. - Common Stock last traded?
    The last trade of GeoVax Labs, Inc. - Common Stock was at 01/08/26 03:01 PM ET
    What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
    The market capitalization of GeoVax Labs, Inc. - Common Stock is 408.18K
    How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
    GeoVax Labs, Inc. - Common Stock has 408K shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.